학술논문

Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T Cells
Document Type
Article
Source
In: Transplantation and Cellular Therapy. (Transplantation and Cellular Therapy, August 2023, 29(8):495-503)
Subject
Language
English
ISSN
26666367